Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Ten23 Health AG, commonly referred to as ten23 health, is a Swiss-based company specialising in the chemicals nec industry. Headquartered in Switzerland, the firm operates across various regions, delivering innovative chemical solutions. Since its establishment, ten23 health has focused on developing unique products that meet the evolving needs of its clients.
The company’s core offerings include specialised chemical products and services tailored to diverse industrial applications. Known for its commitment to quality and innovation, ten23 health has established a strong market presence within the chemicals nec sector. Its strategic milestones and dedication to excellence position it as a notable player in the industry.
+15 vs industry average
ten23 health AG’s score of 47 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chemicals is among the most carbon-intensive industries
The Chemicals industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
ten23 health AG, headquartered in Switzerland and operating in the Chemicals nec industry, reported total Scope 1, 2, and 3 greenhouse gas emissions of approximately 13,131 tonnes CO2e in 2024. This figure includes about 700 kg CO2e from Scope 1, 86.3 tonnes CO2e from Scope 2 (market-based), and 13,044.5 tonnes CO2e from Scope 3.
Looking back, their total emissions were approximately 15,537 tonnes CO2e in 2023, comprising 500 kg CO2e from Scope 1, 112.7 tonnes CO2e from Scope 2 (market-based), and 15,423.3 tonnes CO2e from Scope 3. In 2022, total emissions were around 5,903.9 tonnes CO2e, with 400 kg CO2e from Scope 1, 131.3 tonnes CO2e from Scope 2 (market-based), and 5,771.8 tonnes CO2e from Scope 3. In 2021, ten23 health reported approximately 398.5 tonnes CO2e, with 115.6 tonnes CO2e from Scope 2 (market-based) and 282.9 tonnes CO2e from Scope 3, though Scope 1 data was not available for this year.
ten23 health has demonstrated a strong commitment to climate action through Science Based Targets initiative (SBTi) approved targets. They commit to reducing Scope 1 and Scope 2 GHG emissions by 42% by 2030 from a 2023 base year, and to measure and reduce Scope 3 emissions. The company has also committed to achieving Net-Zero emissions by 2050, aiming for a 90% reduction in combined Scope 1, 2, and 3 emissions by 2050, also from a 2023 base year. These targets have been approved using a streamlined validation route for small and medium-sized enterprises (SMEs).
2030
42% reduction in Scope 2
ten23 health commits to reduce scope 2 GHG emissions 42% by 2030 from a 2023 base year
2030
42% reduction in Scope 2
ten23 health commits to reduce scope 2 GHG emissions 42% by 2030 from a 2023 base year.
2050
90% reduction in all scopes
ten23 health commits to reduce scope 1+2+3 emissions 90% by 2050 from a 2023 base year.
See all 6 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about ten23 health AG’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more